Trevi Therapeutics

/Trevi Therapeutics

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Symbol

Price Range
$10.00 - $10.00

Final Shares
5,500,000

Effective Date
May 7, 2019

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange